Schrodinger Inc (SDGR)

NASD · Healthcare · Health Information Services · USA

Schrodinger Inc is a small cap company (market value between $300 million and $2 billion) in the Health Information Services industry.

Schrodinger Inc offers a computational platform based on physics principles to help organizations discover new drug molecules and materials more efficiently. The company licenses its software to pharmaceutical firms, research institutions, and government agencies globally, while also developing its own therapeutic candidates and working with industry collaborators on molecular discovery projects.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Schrodinger Inc stock.

Our verdict on SDGR

Overvalued: intrinsic value $7.24 per share, market price $25.66, margin of safety -254.3% (as of 2026-11-17).

A 1.0x revenue multiple, discounted for its losses, values the shares at $7.24; the price of $25.66 is 254% above that value.

ETFs with the most weight in SDGR

17 more funds hold it; the full list is part of the paid plan.

More on SDGR

Browse

Peers in Health Information Services

All 40 Health Information Services stocks

Cheaper than SDGR in Health Information Services

8 more in this industry show a wider margin of safety.

Is SDGR undervalued or overvalued?

SDGR is overvalued (as of the 2026-11-17 close). A 1.0x revenue multiple, discounted for its losses, values the shares at $7.24; the price of $25.66 is 254% above that value.

What is the intrinsic value of SDGR?

$7.24 per share (as of the 2026-11-17 close), against a market price of $25.66. That is a margin of safety of -254.3%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.